Skip to content

CONSERVE® 38PF1044Recalls & reported problems

Microport Orthopedics Inc. · CONSERVE® CEMENTLESS FEMORAL COMPONENT 44MM · Class 2 · Implant

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M68438PF10441), received between Feb 21, 2020 and Feb 21, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Dislodged or Dislocated1

Patient problems

  • Metal Related Pathology1
  • Neurological Deficit/Dysfunction1
  • Pain1
  • Reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 21, 2020Device Dislodged or Dislocated; Adverse Event Without Identified Device or Use Problem; Device Dislodged or Dislocated

    ALLEGEDLY, ON (B)(6) 2016 SUBJECT BEGAN WITH PAIN, A PSEUDOTUMOR WAS DIAGNOSED THROUGH ULTRASOUND. REVISION WITH FULL IMPLANT REMOVAL OCCURRED ON (B)(6) 2019. ADDITIONAL INFORMATION ON (B)(6) 2018 SUBJECT EXPERIENCED HIP DISLOCATION OF THE RIGHT SIDE AND RECEIVED A REDUCTION ON (B)(6) 2018. SAE # 052-021R-2. ADDITIONAL INFORMATION RECEIVED ON 11/09/2020 FROM CLINICAL: CORRECTING EXPLANT DATE TO (B0(6) 2019 AND PATIENT'S PERSONAL INFORMATION.

    Patient problems: Metal Related Pathology; Neurological Deficit/Dysfunction; Pain; Reaction

    MAUDE report 9739378 ↗

Other Prosthesis, Hip, Femoral, Resurfacing devices

All Prosthesis, Hip, Femoral, Resurfacing devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.